XML 40 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Intangible Assets and Goodwill (Tables)
 3 Months Ended
Mar. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill
(Dollars in Millions)
 
March 31, 2019
 
December 30, 2018
Intangible assets with definite lives:
 
 
 
 
Patents and trademarks — gross
 
$
35,963

 
35,194

Less accumulated amortization
 
10,548

 
9,784

Patents and trademarks — net
 
25,415

 
25,410

Customer relationships and other intangibles — gross
 
21,766

 
21,334

Less accumulated amortization
 
8,586

 
8,323

Customer relationships and other intangibles — net
 
13,180

 
13,011

Intangible assets with indefinite lives:
 
 
 
 
Trademarks
 
6,912

 
6,937

Purchased in-process research and development (1)
 
1,391

 
2,253

Total intangible assets with indefinite lives
 
8,303

 
9,190

Total intangible assets — net
 
$
46,898

 
47,611



(1)In the fiscal first quarter of 2019, the Company recorded an IPR&D impairment charge of $0.9 billion for the remaining intangible asset value related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios Biopharma Inc. The impairment charge was based on additional information, including clinical data, which became available and led to the Company's decision to abandon the development of AL-8176. A partial impairment charge of $0.8 billion was previously recorded in the fiscal third quarter of 2018 related to the development program of AL-8176.
Goodwill
Goodwill as of March 31, 2019 was allocated by segment of business as follows:
(Dollars in Millions)
 
Consumer
 
Pharm
 
Med Devices
 
Total
Goodwill, net at December 30, 2018
 
$
8,670

 
9,063

 
12,720

 
30,453

Goodwill, related to acquisitions
 
1,176

 
—

 
23

 
1,199

Goodwill, related to divestitures
 
—

 
—

 
—

 
—

Currency translation/Other
 
(116
)
 
(75
)
 
(11
)
 
(202
)
Goodwill, net at March 31, 2019
 
$
9,730

 
8,988

 
12,732

 
31,450


Goodwill is net of approximately $0.3 billion related to the divestiture of the Advanced Sterilization Products business, which was pending and classified as assets held for sale on the Consolidated Balance Sheet as of March 31, 2019.